The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Karyopharm Therapeutics; Merck
Research Funding - Merck
Multicenter phase II study of romidepsin plus lenalidomide for patients with previously untreated peripheral T-cell lymphoma (PTCL).
 
Jia Ruan
Honoraria - BMS; Kite, a Gilead company; Seagen
Consulting or Advisory Role - BMS; Cellectar; Daiichi Sankyo; Kite, a Gilead company; Seagen
Research Funding - AstraZeneca; BMS; Daiichi Sankyo; Pharmacyclics; Seagen
 
Jasmine M. Zain
Honoraria - Kiyowa Kirin; Mundipharma; Seagen; verastem
Consulting or Advisory Role - Legend Biotech ; Ono Pharmaceutical; secura bio; verastem
Speakers' Bureau - Celgene; Mallinckrodt; Seagen
Research Funding - Affimed Therapeutics; crispr therapeutics; OncoTartis; Seagen; secura bio
Travel, Accommodations, Expenses - Seagen
 
Brett Palmer
No Relationships to Disclose
 
Borko Jovanovic
No Relationships to Disclose
 
Xinlei Mi
No Relationships to Disclose
 
Alok Swaroop
No Relationships to Disclose
 
Jane Winter
No Relationships to Disclose
 
Leo I. Gordon
No Relationships to Disclose
 
Reem Karmali
No Relationships to Disclose
 
Barbara Pro
Honoraria - Bayer; Celgene; kiowa; Portola Pharmaceuticals; Seagen; Takeda
Consulting or Advisory Role - Corvus Pharmaceuticals
Research Funding - Celgene (Inst); takeda (Inst); verastem
Travel, Accommodations, Expenses - Seagen; takeda